Related Experiment Videos
Interferon responses of leukocytes in multiple sclerosis
Neurology
|May 1, 1981
Summary
Multiple sclerosis patients show significantly reduced interferon (IFN) production in vitro when exposed to viruses and other immune stimulants. This impaired IFN response is not specific to measles virus and does not correlate with disease severity.
Area of Science:
- Immunology
- Virology
- Neuroscience
Background:
- Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
- Interferon (IFN) is a critical component of the innate immune system, involved in antiviral responses.
- Dysregulation of immune responses is implicated in the pathogenesis of MS.
Purpose of the Study:
- To investigate in vitro interferon (IFN) production by peripheral blood leukocytes in multiple sclerosis (MS) patients compared to healthy donors.
- To determine if the observed IFN response defect is specific to measles virus or a broader immune impairment.
Main Methods:
- Peripheral blood leukocytes were isolated from MS patients and normal donors.
- Leukocytes were stimulated in vitro with measles virus, Newcastle disease virus, Poly(I).Poly(C), and concanavalin A.
- Interferon (IFN) production was measured as a response to these stimuli.
Main Results:
- MS patients exhibited significantly lower mean in vitro IFN responses to measles virus compared to normal donors (15 units vs. 100 units).
- A higher percentage of MS patients failed to mount a significant IFN response.
- This impaired IFN production was observed consistently across various inducers, including Newcastle disease virus, Poly(I).Poly(C), and concanavalin A.
- No correlation was found between the level of IFN response and the clinical stage of MS.
Conclusions:
- Multiple sclerosis patients display a generalized defect in interferon (IFN) production by peripheral blood leukocytes in vitro.
- This impaired IFN response is not specific to measles virus and suggests a broader immune system dysfunction in MS.
- The findings indicate that the level of IFN response does not correlate with disease activity or clinical stage in MS.